TARYNE HENSLEY: Open Payments
NPI 1871839910 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 131 payments from 24 companies in 2025. Trend: 2023 $1,502 · 2024 $3,201 · 2025 $2,607
Food & beverage: $2,408Education: $199
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $385 |
| E.R. Squibb & Sons, L.L.C. | 13 | $329 |
| Janssen Biotech, Inc. | 10 | $304 |
| ABBVIE INC. | 16 | $235 |
| Arcutis Biotherapeutics, Inc. | 13 | $227 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $212 |
| UCB, Inc. | 11 | $170 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $87 |
| Organon LLC | 6 | $72 |
| Incyte Corporation | 3 | $70 |
Products named: NEMLUVIO, Sotyktu, TREMFYA, Bimzelx, SKYRIZI, Zoryve, RINVOQ, ILUMYA.
Industry payments across MO — which companies pay providers there.
